Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Headaches in pregnancy.

Stephen D Silberstein1

  • 1Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, PA, USA. Stephen.Silberstein@jefferson.edu

Neurologic Clinics
|October 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine.

Cephalalgia : an international journal of headache·2025
Same author

Practice advisory for intravenous management of headache disorders in hospitalized patients: a review of the evidence and consensus recommendations.

Regional anesthesia and pain medicine·2025
Same author

Insights from 25 years of onabotulinumtoxinA in migraine - mechanisms and management.

Nature reviews. Neurology·2024
Same author

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials.

Headache·2024
Same author

Clinical factors associated with day-to-day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data.

Headache·2024
Same author

How early can we treat migraine attacks? A perspective based on prodrome.

Med (New York, N.Y.)·2024
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Migraine and tension-type headaches (TTH) are common in pregnancy. While most pregnant individuals with migraine improve, medication use requires careful consideration of fetal risks versus maternal benefits.

Area of Science:

  • Neurology
  • Obstetrics
  • Pharmacology

Background:

  • Migraine and tension-type headaches (TTH) are prevalent primary headache disorders during pregnancy.
  • Pregnancy can trigger new-onset migraine or alter existing migraine patterns, often improving during gestation but recurring postpartum.
  • Serious secondary causes of headache, including stroke, cerebral venous thrombosis, eclampsia, and subarachnoid hemorrhage (SAH), are more frequent in pregnant individuals.

Purpose of the Study:

  • To review the diagnosis and management of primary headache disorders in pregnancy.
  • To discuss the safety and efficacy of diagnostic testing and pharmacologic treatments during pregnancy.
  • To emphasize nonpharmacologic interventions as the preferred approach.

Main Methods:

  • Literature review of diagnostic strategies and treatment options for headaches in pregnancy.

Related Experiment Videos

  • Analysis of risks associated with neuroimaging and medication use in pregnant patients.
  • Evaluation of nonpharmacologic and pharmacologic therapeutic approaches.

    • Main Results:

    • Diagnostic testing aims to rule out organic causes and guide treatment, prioritizing methods with minimal fetal risk.
    • Most medications are not teratogenic, but adverse fetal effects depend on dose, administration, and developmental timing.
    • The risk of untreated severe migraine (status migrainosus) may outweigh medication risks.

    Conclusions:

    • Medication use during pregnancy should be limited but is not absolutely contraindicated.
    • Nonpharmacologic treatments are ideal for managing headaches in pregnancy.
    • Analgesics and preventive therapies are considered secondary options when necessary, with careful risk-benefit assessment.